IGSF10 and cancer: Over the past few years, growing proofs have also validated the definitive role of IGSF10 as a prominent biomarker in a variety of cancers, including osteosarcoma [16], endometrial cancer [17], oral tumour [18], and multitype breast cancers [19, 20, 21].